MedPath
NMPA Approval

人参首乌精

国药准字Z36021025

June 21, 2021

Drug Information

人参首乌精

合剂

每支装10毫升

中药

June 21, 2021

Company Information

Applicant Company

江西省赣江新区直管区新祺周管理处国药北大道231号

Manufacturing Company

江西省赣江新区直管区新祺周管理处国药北大道231号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.